ClinicalTrials.gg
Sign In

Vaginal Diseases clinical trials

The registry lists 43 studies for Vaginal Diseases across more than 10 countries. 5 are recruiting or about to start. 21 of them are mainly about Vaginal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20. Counting its 9 narrower conditions too, such as Vaginosis, Bacterial: 667 studies, 115 open.

Get an email when these change. Save the Vaginal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
32
Status unknown
4
Recruiting
3
Not yet recruiting
2
Terminated
2

Phase

Phase 3
7
Phase 2
6
Phase 1
3
Phase 4
3

Where

United States
10
Italy
4
Sweden
3
Romania
3
Colombia
2
Brazil
2

Who runs them

Shionogi (6) · Gedea Biotech AB (3) · Italfarmaco (3) · Herbarium Laboratorio Botanico Ltda (2) · Peking Union Medical College Hospital (1) · London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's (1) · NTC srl (1) · Universidad Nacional de Colombia (1)

What is being tested here

Drugs under test in Vaginal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ospemifene056
Metronidazole002
Probiotic001
Secnidazole011
Desflurane001
Sevoflurane001
Estradiol001

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 3 Vaginal Diseases studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 3 (100%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
100 (0%)0 (0%)
183 (100%)0 (0%)
303 (100%)0 (0%)
403 (100%)0 (0%)
503 (100%)0 (0%)
653 (100%)0 (0%)
753 (100%)0 (0%)
853 (100%)0 (0%)

Across all 43 studies, recruiting or not: 44% stop at 75 or younger and 35% at 65; 0% take children; 98% are for women only and 2% for men only; 42% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Vaginal Diseases studies take

Of 15 interventional studies with no phase under Vaginal Diseases, half reached primary completion within 7 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase7 mo3–13 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 43 of 43. search them.